Altersbedingte Makuladegeneration - neue Optionen in der Therapie?

Literatur

• 1 Hawkins B S, Bressler N M, Bressler S B. et al . Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.  Arch Ophthalmol. 2004;  122 1597-1611
• 2 Hawkins B S, Miskala P H, Bass E B. et al . Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10.  Arch Ophthalmol. 2004;  122 1616-1628
• 3 Kirchhof B. Makulatranslokation. Bessere Prognosen für AMD-Patienten.  Ophthalmologe. 2002;  99 143
• 4 Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.  Retina. 2005;  25 119-134
• 5 Csaky K. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.  Ophthalmology. 2003;  110 879-881
• 6 Folkman J, Merler E, Abernathy C. et al . Isolation of a tumor factor responsible for angiogenesis.  J Exp Med. 1971;  133 275-288
• 7 Schachat A P. New treatments for age-related macular degeneration.  Ophthalmology. 2005;  112 531-532
• 8 Ferrara N. Vascular endothelial growth factor: basic science and clinical progress.  Endocr Rev. 2004;  25 581-611